| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 430,054 | 602,082 | 276,626 | 258,966 | | Cost of Revenue | 306,660 | 424,014 | 195,433 | 183,644 | | | Gross Profit | 123,394 | 178,068 | 81,193 | 75,322 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 91,252 | 96,348 | 84,839 | 90,650 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,142 | 81,720 | (3,646) | (15,328) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 32,142 | 81,720 | (3,646) | (15,328) | | Interest Expense | 2,504 | 3,150 | 3,327 | 4,212 | | Income Before Tax | 29,638 | 78,570 | (6,973) | (19,540) | | Income Tax Expense | 11,648 | 30,878 | (2,740) | (7,486) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,322) | 48,366 | (6,236) | (14,795) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (9,322) | 48,366 | (6,236) | (14,795) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($9,322) | $48,366 | ($6,236) | ($14,795) |
|
0.11% Nasdaq 
0.01%
Income Statement
